GGrantIndex
← Leaderboards

Ram Yogev

Children'S Memorial Hospital (Chicago)

$19,711,593
Attributed
$19,711,593
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.3M · FY200514
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$19,711,593 · 11

By mechanism

U01$16,658,212 · 2
UM1$2,973,912 · 1
M01$79,469 · 8

Top collaborators

No co-investigators on record.

Most similar at Children'S Memorial Hospital (Chicago)

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchInternationalChildHiv InfectionsEpidemicInfectionChildhoodAids/Hiv ProblemClinical Trial Phase IClinical TreatmentAffectCommunitiesClinical Trials NetworkImmune SystemEnrollmentAreaHuman SubjectBaseAdolescentClinical Research SiteCatchment AreaAids PreventionChicagoPathogenesis

Grant awards (23)

Units for HIV/AIDS Clinical Trials Networks$241,345
UM1 · FY2014 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$1,208,979
UM1 · FY2013 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$1,523,588
UM1 · FY2012 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$1,127,203
U01 · FY2011 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$891,320
U01 · FY2010 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$1,251,667
U01 · FY2009 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,016,531
U01 · FY2008 · AI · contact PI
Units for HIV/AIDS Clinical Trials Networks$2,310,776
U01 · FY2007 · AI · contact PI
PACTG P1021: EMTRICITABINE IN COMBINATION WITH EFAVIRENZ & DIDANOSINE IN ART$12,145
M01 · FY2007 · RR · contact PI
PACTG P1038: HIGH DOSE LOPINAVIR/RITONAVIR WITH OR WITHOUT SAQUINAVIR IN HIV PTS$8,098
M01 · FY2007 · RR · contact PI
PACTG 1020-A: PROTEASE INHIBITOR (BMS 232632) IN COMBINATION REGIMEN IN ART$8,098
M01 · FY2007 · RR · contact PI
Pediatric AIDS Clinical Trials Unit$926,698
U01 · FY2006 · AI · contact PI
PACTG P1038: HIGH DOSE LOPINAVIR/RITONAVIR WITH OR WITHOUT SAQUINAVIR IN HIV PTS$16,137
M01 · FY2006 · RR · contact PI
PACTG 1020-A: PROTEASE INHIBITOR (BMS 232632) IN COMBINATION REGIMEN IN ART$9,682
M01 · FY2006 · RR · contact PI
PACTG P1021: EMTRICITABINE IN COMBINATION WITH EFAVIRENZ & DIDANOSINE IN ART$3,227
M01 · FY2006 · RR · contact PI
Pediatric AIDS Clinical Trials Unit$1,377,953
U01 · FY2005 · AI
Pediatric AIDS Clinical Trials Unit$1,472,423
U01 · FY2004 · AI
Pharmacokinetics of Antiretrovirals Following Gastrostomy Tube Administration$14,289
M01 · FY2004 · RR
PACTG P1030: A PHASE I/II STUDY OF LOPINAVIR/RITONAVIR IN HIV-1 INFECTED INFANTS$7,793
M01 · FY2004 · RR
Pediatric AIDS Clinical Trials Unit$1,338,613
U01 · FY2003 · AI
Pediatric AIDS Clinical Trials Unit$1,345,731
U01 · FY2002 · AI
PEDIATRIC AIDS CLINICAL TRIALS UNIT$1,310,981
U01 · FY2001 · AI
PEDIATRIC AIDS CLINICAL TRIALS UNIT$1,288,316
U01 · FY2000 · AI